# Xeriant, Inc.: overview XERI · OTC · CIK 1481504 · [Industrials](/sectors/industrials.md) · fiscal year ends Jun 30 Pages: [Overview](/companies/xeri.md) · [Financials](/companies/xeri/financials.md) · [Filings](/companies/xeri/filings.md) · [Insiders](/companies/xeri/insiders.md) Latest reported revenue: [−$489](/filings/0001477932-19-005520.md) for Q4 FY2018, three months to 2018-06-30, from the 10-K filed Sep 25, 2019 (XBRL us-gaap:Revenues, accession 0001477932-19-005520). ## Last eight quarters | Line item | Unit | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.00](/filings/0001477932-25-008494.md) | [0.00](/filings/0001477932-26-000862.md) | [0.00](/filings/0001477932-26-003234.md) | not reported | [0.00](/filings/0001477932-25-008494.md) | [0.00](/filings/0001477932-26-000862.md) | [0.00](/filings/0001477932-26-003234.md) | not reported | | Free cash flow | $k | not reported | not reported | not reported | [(174) d](/filings/0001477932-26-005837.md) | not reported | not reported | not reported | [(184) d](/filings/0001477932-26-005837.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY2022 (2022-06-30) | FY2023 (2023-06-30) | FY2024 (2024-06-30) | FY2025 (2025-06-30) | FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [(0.05)](/filings/0001477932-22-007622.md) | not reported | [(0.01)](/filings/0001477932-25-007303.md) | [0.00](/filings/0001477932-26-005837.md) | [0.00](/filings/0001477932-26-005837.md) | | Free cash flow | $k | [(6,947)](/filings/0001477932-23-007646.md) | [(1,177)](/filings/0001477932-24-006252.md) | [(1,430)](/filings/0001477932-25-007303.md) | [(1,290)](/filings/0001477932-26-005837.md) | [(795)](/filings/0001477932-26-005837.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/xeri/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Williams Jones Wealth Management, LLC.](/funds/1788587.md) | 2026-06-30 | $2.1k | 150,288 | | Unchanged | ## Recent filings [All 183 filings](/companies/xeri/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-28 | 16:30 ET | [10-K](/filings/0001477932-26-005837.md) | Annual report, period 2026-06-30 | 0001477932-26-005837 | | 2026-05-15 | 16:26 ET | [10-Q](/filings/0001477932-26-003234.md) | Quarterly report, period 2026-03-31 | 0001477932-26-003234 | | 2026-02-17 | 16:35 ET | [10-Q](/filings/0001477932-26-000862.md) | Quarterly report, period 2025-12-31 | 0001477932-26-000862 | | 2025-11-19 | 16:05 ET | [10-Q](/filings/0001477932-25-008494.md) | Quarterly report, period 2025-09-30 | 0001477932-25-008494 | | 2025-11-12 | 17:10 ET | [8-K](/filings/0001477932-25-008111.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001477932-25-008111 | | 2025-10-02 | 16:44 ET | [10-K](/filings/0001477932-25-007303.md) | Annual report, period 2025-06-30 | 0001477932-25-007303 | | 2025-05-15 | 12:24 ET | [10-Q](/filings/0001477932-25-003761.md) | Quarterly report, period 2025-03-31 | 0001477932-25-003761 | | 2025-04-02 | 06:28 ET | [8-K](/filings/0001477932-25-002373.md) | 5.02 Departure or appointment of officers or directors | 0001477932-25-002373 | | 2025-02-14 | 14:14 ET | [10-Q](/filings/0001477932-25-001010.md) | Quarterly report, period 2024-12-31 | 0001477932-25-001010 | | 2025-01-23 | 06:02 ET | [8-K](/filings/0001477932-25-000403.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-25-000403 | ## Latest annual report [Form 10-K for the fiscal year ended Jun 30, 2026](/filings/0001477932-26-005837.md), filed Sep 28, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1481504 - Tickers: XERI - Exchange: OTC - SIC code: 3721 Aircraft - State of incorporation: not reported - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.